Psychological treatment may reduce the need for healthcare in patients with Crohn's disease

Inflammatory Bowel Diseases

Volumn 13, Issue 6, 2007, Pages 745-752

  Deter, Hans Christian ^a   Keller, Wolfram ^a   Von Wietersheim, Jörn ^b   Jantschek, Günther ^b   Duchmann, Rainer ^a   Zeitz, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Crohn's disease; Health care utilization; Outcome study; Psychological intervention

Indexed keywords

GLUCOCORTICOID; MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGE DISTRIBUTION; ANALYSIS OF COVARIANCE; ANAMNESIS; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DEPRESSION; DRUG DOSE REDUCTION; FEMALE; GERMANY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; LEISURE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; MULTICENTER STUDY; MULTIPLE REGRESSION; PREDICTION; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 34250320422     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20068     Document Type: Article

References (45)

1. Katon W, Korff M v, Liu F, et al. A randomised trial of psychiatric consultation with distressed high utilizers. Gen Hosp Psychiatry. 1992;14:86-98.
2. Verhoefs M, Sutherland L. Outpatient health care utilization of patients with inflammatory bowel disease. Dig Dis. 1995;11:1124-1128.
3. Hay AR, Hay JW. Inflammatory bowel disease: cost of-illness. J Clin Gastroenterol. 1992;14:309-317.
4. Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease - functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379-1386.
5. Drossman D, Leserman J, Mitchel C, et al. Health status and health care use in persons with inflammatory bowel disease: a national sample. Dig Dis Sci. 1991;36:1746-1755.
6. Helzer JE, Chammas S, Norland CC, Stillings WA, Alpers DH. A study of the association between Crohn's disease and psychiatric Illness. Gastroenterology. 1984;86:324-330.
7. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut. 1987;28:1600-1604.
8. Gerbert B. Psychological aspects of Crohn's disease. J Behav Med. 1980;8:649-656.
9. Deter HC, Rapf M, Gladisch R, Rohner R. Psychodiagnostische Verlaufsuntersuchungen von Morbus-Crohn-Patienten während der internistischen Intensivbehandlung. Z Gastroenterol. 1993;31:703-710.
10. Fullwood A, Drossman DA. The relationship of psychiatric illness with gastrointestinal disease. Annu Rev Med. 1995;46:483-496.
11. Levenstein S, Li Z, Almer S, et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:1822-1830.
12. Janke KH, Klump B, Gregor M, Meisner C, Haeuser W. Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:272-286.
13. Bernklev T, Jahnsen J, Aadland E, et al. IBSEN Study Group: health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol. 2004;j39:365-373.
14. van der Eijk I, Vlachonikolis IG, Munkholm P, et al. EC-IBD Study Group: the role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis. 2004;10:392-398.
15. Mussell M, Backer U, Nagel N, Singer MV. Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2004;16:1273-1280.
16. van der Zaag-Loonen H, Grootenhuis MA, Last BF, Derkx HH. Coping strategies and quality of life of adolescents with inflammatory bowel disease. Qual Life Res. 2004;13:1011-1019.
17. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004;66:79-84.
18. von-Wietersheim J, Köhler T, Feiereis H. Relapse - precipitating life events and feelings in patients with inflammatory bowel disease. Psychother Psychosom. 1992;58:103-112.
19. Milne B, Joachim G, Niedhardt J. A stress management programme for inflammatory bowel disease patients. J Adv Nurs. 1986;11:561-567.
20. Schwarz SP, Blanchard EB. Evaluation of a psychological treatment for inflammatory bowel disease. Behav Res Ther. 1991;29:167-177.
21. Smith GD, Watson R, Roger D, et al. Impact of a nurse-led counseling service on quality of life in patients with inflammatory bowel disease. J Adv Nurs. 2002;38:152-160.
22. Elsenbruch S, Langhorst J, Popkirowa K, et al. Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom. 2005;74:277-287.
23. Maunder RG, Esplen MJ. Supportive-expressive group psychotherapy for persons with inflammatory bowel disease. Can J Psychiatry. 2001;46:622-626.
24. Larsson K, Sundberg Hjelm M, Karlbom U, Nordin K, Anderberg UM, Lööf L. A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis. Scand J Gastroenterol. 2003;38:763-769.
25. Kennedy AP, Nelson E, Reeves D, et al. A randomized controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut. 2004;53:1639-1645.
26. Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol. 2005;19:235-244.
27. Jantschek G, Zeitz M, Pritsch M, et al and the German Study Group on Psychosocial Intervention in Crohn's disease. Effect of psychotherapy on the course of Crohn's disease. Scand J Gastroenterol. 1998;33:1289-1296.
28. Keller W, Pritsch M, von Wietersheim J, et al. The German Study Group on Psychosocial Intervention in Crohn's Disease: effect of psychotherapy and relaxation ion the psychosocial and somatic course of Crohn's disease: main results of the German Prospective Multicenter Psychotherapy Treatment Study on Crohn's Disease. J Psychosom Res. 2004;56:687-696.
29. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. Gastroenterology. 1976;70:439-444.
30. Malchow H, Ewe K, Brandes JW, et al. European cooperative Crohn's disease study (ECCDS): results of drug treatment. Gastroenterology. 1984;86:249-266.
31. Beck AT, Ward CH, Medelson M, Mock F, Erbaugh F. An inventory of measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
32. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologist Press; 1970.
33. Bullinger M. Forschungsinstrumente zur Erfassung der Lebensqualität bei Krebs - ein Überblick. In: Verres R, Hasenbring M editors. Psychosoziale Onkologie. Jahrbuch der Medizinischen Psychologie 3 (S.45-57). Berlin: Springer; 1989.
34. Kaplan MA, Korelitz BJ. Narcotic dependence in inflammatory bowel disease. J Clin Gastroenterol. 1988;10:275-278.
35. Husain A, Triadafilopoulos G. Communicating with patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:444-450; discussion, 451.
36. Borgaonkar MR, Townson G, Donnelly M, Irvine JE. Providing disease-related information worsens health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:264-269.
37. Bregenzer N, Lange A, Fürst A, Gross V, Schölmerich J, Andus T. Patient education in inflammatory bowel disease does not influence patients' knowledge and long-term psychosocial well-being. Z Gastroenterol. 2005;43:367-371.
38. Deter HC. Cost benefit analysis of psychosomatic therapy in asthma. J Psychosom Res. 1986;30:173-182.
39. Brinkmann R, Deter HC, Brohl J, Eisele H. Ambulante Gruppentherapie bei Patienten mit chronischer Polyarthritis [Outpatient group therapy in patients with rheumatoid arthritis]. In: Deter HC, Schueffel W, editors. Gruppen mit körperlich Kranken. Berlin: Springer; 1988.
40. Seibeni S, Cortinovis I, Beretta L, et al. Gruppo di Studio per le Malattie Inflammatorie Intestinali: gender and disease activity influence health-related quality of life in inflammatory bowel diseases. Hepatogastroenterology. 2005;52:509-515.
41. Binder V. Epidemiology, course and socio-economic influence of inflammatory bowel disease. Schweiz Med Wochenschr. 1988;118:738-742.
42. Mitchell CM, Guyatt G, Singer J, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol. 1988;10:306-310.
43. Hellers G. Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir Scand. 1979;490(Suppl):1-84.
44. Farmer RG, Whelan G, Fazio UW. Long-term follow-up of patients with Crohn's disease. Gastroenterolgy. 1985;88:1818-1825.
45. Scarpa M, Angriman I, Ruffolo C et al. Health-related quality of life after restorative proctocolectomy for ulcerative colitis: long-term results. World J Surg. 2004;28:124-129.